Devyser
Sweden - ÅrstaDiagnostics
Focus: Devyser is a genetic diagnostics company specializing in NGS (next-generation sequencing) analysis for rare disease detection. Based in Sweden with 51-200 employees, they operate in the specialized diagnostics market.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Employees
51-200
Open Jobs
0
About Devyser
AI assessmentNot HiringNo open roles listed right now. Follow Devyser to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Prospective Collection of Whole Blood Specimens From RhD Negative Pregnant Women
Rhesus D GenotypeClinical Trials (1)
NCT06690099Prospective Collection of Whole Blood Specimens From RhD Negative Pregnant Women
N/AHelp build intelligence for Devyser
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.